GB8909891D0
(en)
*
|
1989-04-28 |
1989-06-14 |
Riker Laboratories Inc |
Device
|
UA26230A
(uk)
*
|
1990-03-02 |
1999-07-19 |
Глексо Груп Лімітед |
Іhгалятор для спільhого використаhhя з лікувальhим блоком і лікувальhий блок
|
US6536427B2
(en)
*
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
SK280968B6
(sk)
*
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Balenie medikamentu na použite v inhalačnom prístroji
|
GB9004781D0
(en)
*
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
SK280014B6
(sk)
*
|
1992-09-11 |
1999-07-12 |
Glaxo Group Limited |
Inhalátor
|
SE9203570D0
(sv)
*
|
1992-11-27 |
1992-11-27 |
Astra Ab |
Inhaler for multiple use
|
JPH08504634A
(ja)
*
|
1992-12-24 |
1996-05-21 |
ローン−プーラン・ロレ・リミテツド |
吸入装置
|
US5896855A
(en)
*
|
1992-12-24 |
1999-04-27 |
Rhone-Poulenc Rorer Limited |
Multi dose inhaler apparatus
|
GB9326574D0
(en)
*
|
1993-12-31 |
1994-03-02 |
King S College London |
Dry power inhalers
|
JPH07219571A
(ja)
*
|
1994-01-31 |
1995-08-18 |
Yukihiko Takino |
カラオケ曲目表示装置
|
PT101450B
(pt)
*
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
GB9417399D0
(en)
|
1994-08-30 |
1994-10-19 |
Scherer Corp R P |
Ocular treatment device
|
ES2208980T3
(es)
*
|
1994-08-30 |
2004-06-16 |
Pharmacia Ab |
Embalaje para dosis fluidas, dispositivo de tratamiento ocular y uso del mismo.
|
DE29501527U1
(de)
*
|
1995-02-01 |
1995-03-30 |
Hugo Kern und Liebers GmbH & Co. Platinen- und Federnfabrik, 78713 Schramberg |
Vorrichtung zur Erzeugung inhalierbarer Wirkstoffpartikel
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
SE9503344D0
(sv)
*
|
1995-09-27 |
1995-09-27 |
Astra Ab |
Inhalation device
|
JP2000503565A
(ja)
|
1996-01-03 |
2000-03-28 |
グラクソ、グループ、リミテッド |
吸入装置
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
US5871010A
(en)
*
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
GB9626233D0
(en)
*
|
1996-12-18 |
1997-02-05 |
Chawla Brinda P S |
Medicament packaging and deliveery device
|
SE9700424D0
(sv)
*
|
1997-02-07 |
1997-02-07 |
Astra Ab |
Powder inhaler
|
US6006747A
(en)
*
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
CA2212430A1
(en)
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Inhalation device
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
NZ504021A
(en)
*
|
1997-10-17 |
2003-04-29 |
Systemic Pulmonary Delivery Lt |
Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US7089935B1
(en)
*
|
1999-01-22 |
2006-08-15 |
Glaxo Group Limited |
Inhalation device
|
GB9905538D0
(en)
|
1999-03-10 |
1999-05-05 |
Glaxo Group Ltd |
A device
|
US6601729B1
(en)
|
1999-03-26 |
2003-08-05 |
Papp Enterprises, Llc |
Automated portable medication radial dispensing apparatus and method using a carrier tape
|
GB9909354D0
(en)
*
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
GB9909357D0
(en)
*
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
US6730066B1
(en)
|
1999-08-03 |
2004-05-04 |
Pharmacia Ab |
Liquid delivery container
|
GB9925934D0
(en)
|
1999-11-03 |
1999-12-29 |
Glaxo Group Ltd |
Novel apparatus and process
|
US20010029947A1
(en)
*
|
1999-12-17 |
2001-10-18 |
Steve Paboojian |
Receptacles to facilitate the extraction of powders
|
US7171965B2
(en)
*
|
2000-02-01 |
2007-02-06 |
Valois S.A.S. |
Breath actuated dry powder inhaler and tape dose strip
|
GB0004456D0
(en)
*
|
2000-02-26 |
2000-04-19 |
Glaxo Group Ltd |
Medicament dispenser
|
DE10011120A1
(de)
*
|
2000-03-09 |
2001-09-13 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
WO2001072605A1
(en)
*
|
2000-03-27 |
2001-10-04 |
Dura Pharmaceuticals, Inc. |
Containers for individual doses of an inhalable pharmaceutical
|
WO2001085136A2
(en)
*
|
2000-05-10 |
2001-11-15 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US20030003057A1
(en)
*
|
2000-07-07 |
2003-01-02 |
Jeffry Weers |
Methods for administering leuprolide by inhalation
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
GB0012465D0
(en)
*
|
2000-05-24 |
2000-07-12 |
Glaxo Group Ltd |
Monitoring method
|
GB0013619D0
(en)
*
|
2000-06-06 |
2000-07-26 |
Glaxo Group Ltd |
Sample container
|
GB0014851D0
(en)
*
|
2000-06-16 |
2000-08-09 |
Glaxo Group Ltd |
Novel pharmaceutical formulation
|
GB0015034D0
(en)
*
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Inhalation device
|
TWI224512B
(en)
*
|
2000-06-23 |
2004-12-01 |
Norton Healthcare Ltd |
Reservoir pressure system for medicament inhaler
|
US7080644B2
(en)
*
|
2000-06-28 |
2006-07-25 |
Microdose Technologies, Inc. |
Packaging and delivery of pharmaceuticals and drugs
|
EP1301230A1
(en)
|
2000-07-15 |
2003-04-16 |
Glaxo Group Limited |
Medicament dispenser
|
WO2002009674A2
(en)
*
|
2000-07-28 |
2002-02-07 |
Inhale Therapeutic Systems, Inc. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
BRPI0113042B8
(pt)
|
2000-08-05 |
2021-05-25 |
Glaxo Group Ltd |
composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
WO2002013897A2
(en)
|
2000-08-14 |
2002-02-21 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
AUPR020400A0
(en)
*
|
2000-09-19 |
2000-10-12 |
Glaxo Wellcome Australia Ltd |
Inhalation device
|
GB0026647D0
(en)
*
|
2000-10-31 |
2000-12-13 |
Glaxo Group Ltd |
Medicament dispenser
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
DE10111945B4
(de)
*
|
2001-03-13 |
2006-03-09 |
Alexander Christ |
Kapselspender
|
ES2296923T3
(es)
|
2001-03-22 |
2008-05-01 |
Glaxo Group Limited |
Derivados formanilidas como agonistas del adrenorreceptor beta2.
|
US6766799B2
(en)
*
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
BR0209271A
(pt)
|
2001-04-30 |
2004-06-15 |
Glaxo Group Ltd |
Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
|
US7766013B2
(en)
*
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
FI20011317A0
(sv)
|
2001-06-20 |
2001-06-20 |
Orion Corp |
Pulverinhalator
|
JP2004537377A
(ja)
*
|
2001-08-09 |
2004-12-16 |
グラクソ グループ リミテッド |
製薬組成物を有する吸入装置
|
USRE44874E1
(en)
|
2001-09-14 |
2014-04-29 |
Glaxo Group Limited |
Phenethanolamine derivatives for treatment of respiratory diseases
|
AU2002333644A1
(en)
|
2001-09-17 |
2003-04-01 |
Glaxo Group Limited |
Dry powder medicament formulations
|
CA2460904C
(en)
|
2001-09-19 |
2011-03-22 |
Advent Pharmaceuticals Pty Ltd |
An inhaler for delivering metered doses of powdered medicament
|
GB0125135D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0125132D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0125134D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0127989D0
(en)
*
|
2001-11-22 |
2002-01-16 |
Glaxo Group Ltd |
Medicament dispensing system
|
GB0130055D0
(en)
*
|
2001-12-14 |
2002-02-06 |
Technology Innovation Ltd |
Medicament packaging
|
MXPA04005865A
(es)
*
|
2001-12-19 |
2004-09-13 |
Nektar Therapeutics |
Suministro de aminoglucosidos a los pulmones.
|
GB0217199D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0201677D0
(en)
*
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
WO2003061744A1
(en)
|
2002-01-25 |
2003-07-31 |
Glaxo Group Limited |
Medicament dispenser
|
AU2003216401A1
(en)
*
|
2002-03-01 |
2003-09-16 |
Glaxo Group Limited |
Rotary blending apparatus and system
|
EP1490031A1
(en)
*
|
2002-03-07 |
2004-12-29 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
GB0205572D0
(en)
*
|
2002-03-09 |
2002-04-24 |
Chawla Brinda P S |
Medicament delivery and packaging
|
WO2003095332A1
(en)
*
|
2002-03-26 |
2003-11-20 |
Glaxo Group Limited |
A method for forming a laminate assembly and products formed thereby
|
GR1004350B
(el)
*
|
2002-03-29 |
2003-09-26 |
|
Συσκευη εισπνοων ξηρης σκονης
|
US20030235538A1
(en)
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
UA80123C2
(en)
*
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
AU2003222841A1
(en)
|
2002-04-25 |
2003-11-10 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
JP2005524134A
(ja)
*
|
2002-04-25 |
2005-08-11 |
グラクソ グループ リミテッド |
環境条件を検知するための磁気音響センサーシステムおよびそれに関連する方法
|
GB0209526D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0209528D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
JP2005526261A
(ja)
*
|
2002-05-15 |
2005-09-02 |
グラクソ グループ リミテッド |
医薬包装内の温度および水分プロファイルを測定するための微小電気機械システムおよび方法
|
GB0216831D0
(en)
*
|
2002-07-19 |
2002-08-28 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0217198D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
WO2004011067A1
(en)
|
2002-07-25 |
2004-02-05 |
Glaxo Group Limited |
Medicament dispenser
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0217196D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
WO2004011068A1
(en)
|
2002-07-25 |
2004-02-05 |
Glaxo Group Limited |
Medicament dispenser
|
US20070139442A1
(en)
*
|
2002-09-13 |
2007-06-21 |
Robinson Karl E |
Coated blending system
|
GB0221493D0
(en)
*
|
2002-09-17 |
2002-10-23 |
Glaxo Group Ltd |
Method for loading a medicament dispenser with a medicament carrier
|
US6962266B2
(en)
*
|
2002-10-04 |
2005-11-08 |
Ecolab Inc. |
Method and apparatus for using a unit dose dispenser
|
ES2291733T3
(es)
*
|
2002-10-22 |
2008-03-01 |
Glaxo Group Limited |
Compuestos de ariletanolamina medicinales.
|
SI1556342T1
(sl)
|
2002-10-28 |
2008-08-31 |
Glaxo Group Ltd |
Fenetanolaminski derivat za zdravljenje respiratornih bolezni
|
WO2004060260A2
(en)
*
|
2002-12-18 |
2004-07-22 |
Glaxo Group Limited |
Drug delivery system with vented mouthpiece
|
US20040173211A1
(en)
*
|
2003-01-14 |
2004-09-09 |
Boehringer Ingelheim International Gmbh |
Powder inhaler
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0303870D0
(en)
*
|
2003-02-20 |
2003-03-26 |
Norton Healthcare Ltd |
Pre-metered dose magazine for breath-actuated dry powder inhaler
|
EP1603810B1
(en)
*
|
2003-03-15 |
2010-08-11 |
Brin Tech International Limited |
Medicament package
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
SE527069C2
(sv)
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
GB0315509D0
(en)
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
PE20050250A1
(es)
|
2003-07-17 |
2005-04-08 |
Glaxo Group Ltd |
Antagonistas de los receptores muscarinicos de la acetilcolina
|
GB0317374D0
(en)
*
|
2003-07-24 |
2003-08-27 |
Glaxo Group Ltd |
Medicament dispenser
|
PL1677795T3
(pl)
|
2003-10-14 |
2011-05-31 |
Glaxo Group Ltd |
Antagoniści receptora muskarynowego acetylocholiny
|
AP2006003575A0
(en)
|
2003-10-17 |
2006-04-30 |
Glaxo Group Ltd |
Muscarinic acetylcholine receptor antagonists.
|
GB2407042B
(en)
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
GB0324654D0
(en)
*
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
WO2005044187A2
(en)
*
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
AR046225A1
(es)
|
2003-11-04 |
2005-11-30 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
SE0303570L
(sv)
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
WO2005053647A1
(en)
*
|
2003-12-03 |
2005-06-16 |
Microdrug Ag |
Medical product containing tiotropium
|
US7631812B2
(en)
*
|
2003-12-10 |
2009-12-15 |
Williams Troy P |
Foldable transaction card systems
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
CN101018580B
(zh)
*
|
2004-02-06 |
2010-07-14 |
微计量技术有限公司 |
与吸入装置一起使用的泡罩包装
|
GB2410947B
(en)
*
|
2004-02-11 |
2008-09-17 |
Cambridge Lab Ltd |
Pharmaceutical compounds
|
JP4825138B2
(ja)
*
|
2004-02-16 |
2011-11-30 |
グラクソ グループ リミテッド |
薬剤ディスペンサー用カウンター
|
EP1725236A4
(en)
*
|
2004-03-11 |
2009-05-13 |
Glaxo Group Ltd |
NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS
|
US7384946B2
(en)
|
2004-03-17 |
2008-06-10 |
Glaxo Group Limited |
M3 muscarinic acetylcholine receptor antagonists
|
BRPI0509382A
(pt)
|
2004-04-02 |
2007-09-18 |
Glaxo Group Ltd |
processo para a preparação de um sal monocloridrato de composto, monocloridrato cristalino, processo para obter monocloridrato cristalino, método para a profilaxia ou o tratamento de uma condição clìnica em um mamìfero, uso de monocloridrato cristalino, formulação farmacêutica, e, combinação
|
AU2004319427B2
(en)
*
|
2004-04-24 |
2011-04-21 |
Inrange Systems, Inc. |
Integrated, non-sequential, remote medication management and compliance system
|
US7828147B2
(en)
*
|
2004-04-24 |
2010-11-09 |
Inrange Systems, Inc. |
Multi-layer medication carrier
|
TWI363759B
(en)
|
2004-04-27 |
2012-05-11 |
Glaxo Group Ltd |
Muscarinic acetylcholine receptor antagonists
|
EP1747219A4
(en)
|
2004-05-13 |
2010-05-26 |
Glaxo Group Ltd |
Antagonists of muscarinic acetylcholine receptor
|
AR049384A1
(es)
|
2004-05-24 |
2006-07-26 |
Glaxo Group Ltd |
Derivados de purina
|
PL1891974T3
(pl)
|
2004-05-31 |
2010-12-31 |
Almirall Sa |
Kombinacje zawierające środki przeciwmuskarynowe i inhibitory PDE4
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
SE530006C2
(sv)
*
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
SE0401654D0
(sv)
*
|
2004-06-24 |
2004-06-24 |
Astrazeneca Ab |
A support structure for a medicament
|
FR2872798B1
(fr)
*
|
2004-07-09 |
2007-10-05 |
Valois Sas |
Ensemble de blisters pour dispositif d'inhalation
|
GB0418278D0
(en)
*
|
2004-08-16 |
2004-09-15 |
Glaxo Group Ltd |
Medicament dispenser
|
EA200700743A1
(ru)
*
|
2004-10-06 |
2007-10-26 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Устройство для распыления порошка, устройство для хранения порошка и способ распыления порошка
|
EP1812778A2
(en)
*
|
2004-11-12 |
2007-08-01 |
Glaxo Group Limited |
Sensor system with acoustic transducer
|
GB0427856D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Maniflod for use in medicament dispenser
|
GB0427853D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427858D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
KR20070097106A
(ko)
*
|
2005-01-11 |
2007-10-02 |
글락소 그룹 리미티드 |
베타-2 아드레날린성 효능제의 신나메이트 염
|
FR2881111B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881119B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881118B1
(fr)
*
|
2005-01-25 |
2007-04-20 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881117B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
CN104177448A
(zh)
|
2005-02-10 |
2014-12-03 |
葛兰素集团有限公司 |
使用预分选技术制备乳糖的方法以及由此形成的药物制剂
|
WO2006086130A2
(en)
*
|
2005-02-10 |
2006-08-17 |
Glaxo Group Limited |
Process for crystallizing lactose particles for use in pharmaceutical formulations
|
MY145281A
(en)
|
2005-03-25 |
2012-01-13 |
Glaxo Group Ltd |
Novel compounds
|
AR053450A1
(es)
|
2005-03-25 |
2007-05-09 |
Glaxo Group Ltd |
Derivados de 3,4-dihidro-pirimido(4,5-d)pirimidin-2-(1h)-ona 1,5,7 trisustituidos como inhibidores de la quinasa p38
|
US20090042843A1
(en)
*
|
2005-05-04 |
2009-02-12 |
Boehringer Ingelheim International Gmbh |
Inhalation Device Containing Plural Doses of a Pharmaceutical Composition
|
GB0509952D0
(en)
*
|
2005-05-16 |
2005-06-22 |
Glaxo Group Ltd |
Fault indicator
|
ES2265276B1
(es)
|
2005-05-20 |
2008-02-01 |
Laboratorios Almirall S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
|
GB0514501D0
(en)
*
|
2005-07-14 |
2005-08-24 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
DE102005035705A1
(de)
|
2005-07-27 |
2007-02-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Arzneimittelblister
|
GB0515584D0
(en)
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
US20080234315A1
(en)
*
|
2005-08-02 |
2008-09-25 |
Jakob Busch-Petersen |
M3 Muscarinic Acetylcholine Receptor Antagonists
|
WO2007016639A2
(en)
*
|
2005-08-02 |
2007-02-08 |
Glaxo Group Limited |
M3 muscarinic acetylcholine receptor antagonists
|
GB0516168D0
(en)
*
|
2005-08-05 |
2005-09-14 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
EP1937068A4
(en)
|
2005-08-18 |
2010-08-04 |
Glaxo Group Ltd |
ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
US20070068837A1
(en)
*
|
2005-09-29 |
2007-03-29 |
D Angelis Bruno S |
Wound dressing dispenser
|
GB0521563D0
(en)
|
2005-10-21 |
2005-11-30 |
Glaxo Group Ltd |
Novel compounds
|
AR058289A1
(es)
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
AR058290A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Dispensador de medicamento
|
AU2007210177C1
(en)
|
2006-01-31 |
2012-11-01 |
Oriel Therapeutics, Inc. |
Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
|
CN101437562A
(zh)
*
|
2006-03-03 |
2009-05-20 |
Stc.Unm公司 |
具有气动力弹性分散机构的干粉吸入器
|
US8127763B2
(en)
*
|
2006-03-03 |
2012-03-06 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
GB0605150D0
(en)
*
|
2006-03-14 |
2006-04-26 |
Glaxo Group Ltd |
Counter For Use With A Medicament Dispenser
|
EP1844808A1
(de)
*
|
2006-04-13 |
2007-10-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Medikamenten-Ausgabevorrichtung
|
EP1844809A1
(de)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator
|
CA2649509A1
(en)
|
2006-04-20 |
2007-11-01 |
Glaxo Group Limited |
Novel compounds
|
GR1005620B
(el)
*
|
2006-05-09 |
2007-09-03 |
|
Βελτιωση συσκευης εισπνοων ξηρης σκονης
|
GR1005668B
(el)
*
|
2006-05-09 |
2007-10-02 |
|
Συσκευη εισπνοων ξηρης σκονης για την ταυτοχρονη χορηγηση περισσοτερων απο μιας φαρμακευτικων ουσιων
|
DE102006023662A1
(de)
*
|
2006-05-18 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
US9457161B2
(en)
|
2006-05-18 |
2016-10-04 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
FR2904229B1
(fr)
*
|
2006-07-25 |
2008-10-10 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
JP2009545579A
(ja)
|
2006-08-01 |
2009-12-24 |
グラクソ グループ リミテッド |
ピラゾロ[3,4−b]ピリジン化合物、及びpde4阻害薬としてのその使用
|
AU2007309412B2
(en)
|
2006-10-25 |
2011-10-20 |
Novartis Ag |
Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
|
GB0622827D0
(en)
|
2006-11-15 |
2006-12-27 |
Glaxo Group Ltd |
Sheet driver for use in a drug dispenser
|
EP1925295A1
(de)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Stabile Pulverformulierung enthaltend ein Anticholinergikum
|
US8225784B2
(en)
*
|
2006-12-11 |
2012-07-24 |
Valois Sas |
Fluid product dispensing device
|
FR2909643B1
(fr)
*
|
2006-12-11 |
2011-03-04 |
Valois Sas |
Dispositif de distribution de produit fluide
|
US20080163610A1
(en)
*
|
2007-01-05 |
2008-07-10 |
Matthew Thomas Baird |
Method and system for regenerating exhaust system filtering and catalyst components using variable high engine idle
|
ES2306595B1
(es)
|
2007-02-09 |
2009-09-11 |
Laboratorios Almirall S.A. |
Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
US8616199B2
(en)
|
2007-03-16 |
2013-12-31 |
Canon Kabushiki Kaisha |
Inhaler and ejection head unit attachable to the inhaler
|
PE20081889A1
(es)
|
2007-03-23 |
2009-03-05 |
Smithkline Beecham Corp |
Indol carboxamidas como inhibidores de ikk2
|
JP5198801B2
(ja)
*
|
2007-05-30 |
2013-05-15 |
株式会社吉野工業所 |
吸引式投薬器
|
WO2008156586A2
(en)
*
|
2007-06-12 |
2008-12-24 |
Alkermes, Inc. |
Inhalation device for powdered substances
|
WO2009007068A1
(en)
*
|
2007-07-06 |
2009-01-15 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
ES2569359T3
(es)
*
|
2007-07-06 |
2016-05-10 |
Vectura Delivery Devices Limited |
Inhalador
|
EP2011536A1
(en)
*
|
2007-07-06 |
2009-01-07 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Inhaler
|
ES2320961B1
(es)
|
2007-11-28 |
2010-03-17 |
Laboratorios Almirall, S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
|
JP2011507593A
(ja)
|
2007-12-20 |
2011-03-10 |
アストラゼネカ・アクチエボラーグ |
粉末854を脱凝集解体する装置ならびに方法
|
EP2244771A4
(en)
*
|
2008-01-23 |
2013-11-06 |
Astrazeneca Ab |
MEDICINE-CONTAINING DISPENSER WITH AN INDICATION FOR DISPLAYING INFORMATION FOR A USER
|
EP2082759A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
EP2082764A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
EP2082758A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
EP2096105A1
(en)
|
2008-02-28 |
2009-09-02 |
Laboratorios Almirall, S.A. |
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2108641A1
(en)
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
|
EP2113503A1
(en)
|
2008-04-28 |
2009-11-04 |
Laboratorios Almirall, S.A. |
New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
|
GB0810857D0
(en)
*
|
2008-06-13 |
2008-07-23 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
US8517009B2
(en)
*
|
2008-07-13 |
2013-08-27 |
Map Pharmaceuticals, Inc. |
Methods and apparatus for delivering aerosolized medication
|
GB2462611A
(en)
*
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
US20110053866A1
(en)
*
|
2008-08-12 |
2011-03-03 |
Biovail Laboratories International (Barbados) S.R.L. |
Pharmaceutical compositions
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
GB2463283A
(en)
*
|
2008-09-08 |
2010-03-10 |
Cambridge Lab |
3,11b-cis-dihydrotetrabenazine for use in treating asthma
|
GB2463452A
(en)
*
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
|
MX2011003244A
(es)
|
2008-09-26 |
2011-04-28 |
Oriel Therapeutics Inc |
Inhaladores con discos de vias aereas con canales de vias aereas discretas y discos y metodos relacionados.
|
MX2011003233A
(es)
|
2008-09-26 |
2011-04-28 |
Oriel Therapeutics Inc |
Inhaladores de polvo seco con miembros de perforacion doble y dispositivos y metodos relacionados.
|
CA2732826C
(en)
*
|
2008-09-26 |
2017-08-22 |
Oriel Therapeutics, Inc. |
Inhaler mechanisms with radially biased piercers and related methods
|
WO2010039201A2
(en)
*
|
2008-09-30 |
2010-04-08 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
|
WO2010039202A2
(en)
*
|
2008-10-01 |
2010-04-08 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with rotating piercing mechanisms and related devices and methods
|
RU2514318C2
(ru)
*
|
2008-10-08 |
2014-04-27 |
Астразенека Аб |
Ингалятор со звуковыми индикаторными средствами
|
GB201020130D0
(en)
*
|
2010-11-26 |
2011-01-12 |
Vectura Delivery Devices Ltd |
Inhaler
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
EP2198908A1
(en)
*
|
2008-12-19 |
2010-06-23 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
UY32297A
(es)
|
2008-12-22 |
2010-05-31 |
Almirall Sa |
Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
|
AU2010219097A1
(en)
|
2009-01-13 |
2011-08-04 |
Glaxo Group Limited |
Pyrimidinecarboxamide derivatives as inhibitors of SYK kinase
|
NZ574666A
(en)
*
|
2009-02-05 |
2009-04-30 |
Nexus6 Ltd |
A medicament inhaler holder that uses optical means to count and display the number of doses used
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
EP2221055A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
|
EP2221297A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
|
PT3578169T
(pt)
|
2009-02-26 |
2024-07-29 |
Glaxo Group Ltd |
Formulações farmacêuticas compreendendo 4-{(1r)-2-[(2,6- diclorobenzil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2- (hidroximetil)fenol
|
EP2226323A1
(en)
|
2009-02-27 |
2010-09-08 |
Almirall, S.A. |
New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
|
EP2228368A1
(en)
|
2009-03-12 |
2010-09-15 |
Almirall, S.A. |
Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
|
US8399436B2
(en)
|
2009-04-24 |
2013-03-19 |
Glaxo Group Limited |
N-pyrazolyl carboxamides as CRAC channel inhibitors
|
EP2421834A1
(en)
|
2009-04-24 |
2012-02-29 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
DE202009006141U1
(de)
|
2009-04-25 |
2009-08-27 |
Boehringer Ingelheim International Gmbh |
Inhalator
|
US9713575B2
(en)
|
2009-05-07 |
2017-07-25 |
Gea Process Engineering Limited |
Tablet production module and method for continuous production of tablets
|
US8985102B2
(en)
*
|
2009-05-18 |
2015-03-24 |
Adamis Pharmaceuticals Corporation |
Dry powder inhalers
|
US8931479B2
(en)
|
2009-05-18 |
2015-01-13 |
Norton Healthcare Limited |
Dry-powder inhaler
|
WO2010133322A1
(en)
|
2009-05-18 |
2010-11-25 |
Norton Healthcare Limited |
Dry-powder inhaler
|
DK2432532T3
(da)
|
2009-05-18 |
2014-10-06 |
Norton Healthcare Ltd |
Tørpulverinhalator
|
WO2010135253A2
(en)
|
2009-05-18 |
2010-11-25 |
3M Innovative Properties Company |
Dry powder inhaler dose counters
|
MX2011012265A
(es)
*
|
2009-05-21 |
2012-04-11 |
Microdose Therapeutx Inc |
Sistema de casete rotatorio para inhalador de polvo seco.
|
US8985101B2
(en)
|
2009-05-21 |
2015-03-24 |
Microdose Therapeutx, Inc. |
Method and device for clamping a blister within a dry powder inhaler
|
AR077101A1
(es)
|
2009-06-16 |
2011-08-03 |
Schering Corp |
Esteroides de heteroarilo (3,2-c), como agonistas de receptor glucocorticoide, composiciones y usos de los mismos
|
EP2448623B1
(en)
|
2009-07-01 |
2017-12-20 |
AstraZeneca AB |
Dispenser and method for entraining powder in an airflow
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
ES2654423T3
(es)
|
2009-11-05 |
2018-02-13 |
Glaxosmithkline Llc |
Inhibidor de bromodominio de benzodiacepina
|
WO2011054851A1
(en)
|
2009-11-05 |
2011-05-12 |
Glaxosmithkline Llc |
Novel process
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
HUE026421T2
(en)
|
2009-11-05 |
2016-05-30 |
Glaxosmithkline Llc |
Benzodiazepine Bromine Domain Inhibitor
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
EP2322176A1
(en)
|
2009-11-11 |
2011-05-18 |
Almirall, S.A. |
New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
|
AU2010319328A1
(en)
|
2009-11-12 |
2012-05-31 |
Stc.Unm |
Dry powder inhaler with flutter dispersion member
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
TR200909791A2
(tr)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Salmeterol ve flutikazon içeren farmasötik bileşim@
|
EP3431128A1
(en)
|
2010-01-05 |
2019-01-23 |
MicroDose Therapeutx, Inc. |
Inhalation device and method
|
US8490795B2
(en)
|
2010-02-01 |
2013-07-23 |
Mallinckrodt Llc |
Container and method for facilitating disposal of unused pharmaceutical product
|
US9046403B2
(en)
*
|
2010-02-01 |
2015-06-02 |
Mallinckrodt Llc |
Systems and methods for managing use of a medicament
|
JP2013523375A
(ja)
*
|
2010-04-13 |
2013-06-17 |
ビルギチ,マフムト |
乾燥粉末吸入器のマウスピースボタン
|
EP2380890A1
(en)
|
2010-04-23 |
2011-10-26 |
Almirall, S.A. |
New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
EP2386555A1
(en)
|
2010-05-13 |
2011-11-16 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
|
EP2394998A1
(en)
|
2010-05-31 |
2011-12-14 |
Almirall, S.A. |
3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
|
FR2961186B1
(fr)
*
|
2010-06-11 |
2012-07-13 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
ES2526671T3
(es)
|
2010-06-22 |
2015-01-14 |
Glaxosmithkline Llc |
Compuestos de benzotriazoldiazepina inhibidores de bromodominios
|
FR2962345B1
(fr)
|
2010-07-09 |
2013-06-21 |
Valois Sas |
Inhalateur unidose de poudre seche pour blister pelable.
|
CN103118727B
(zh)
*
|
2010-07-21 |
2015-11-25 |
阿斯利康(瑞典)有限公司 |
吸入器
|
WO2012025473A1
(en)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Cc.chemokine receptor 4 antagonists
|
WO2012025474A1
(en)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Indazole compounds
|
JP5792308B2
(ja)
|
2010-08-31 |
2015-10-07 |
グラクソ グループ リミテッドGlaxo Group Limited |
水分制御特性を示す乾燥粉末吸入薬物製品及びその投与方法
|
JP5792307B2
(ja)
|
2010-08-31 |
2015-10-07 |
グラクソ グループ リミテッドGlaxo Group Limited |
水分制御特性を示す乾燥粉末吸入薬物製品及びその投与方法
|
EP2441755A1
(en)
|
2010-09-30 |
2012-04-18 |
Almirall, S.A. |
Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
|
ES2532213T3
(es)
|
2010-10-21 |
2015-03-25 |
Glaxo Group Limited |
Compuestos de pirazol que actúan contra afecciones alérgicas, inmunitarias e inflamatorias
|
JP2013544794A
(ja)
|
2010-10-21 |
2013-12-19 |
グラクソ グループ リミテッド |
アレルギー性障害、炎症性障害及び免疫障害に作用するピラゾール化合物
|
WO2012064286A1
(en)
|
2010-11-11 |
2012-05-18 |
Agency For Science, Technology And Research |
Targeting metabolic enzymes in human cancer
|
EP2457900A1
(en)
|
2010-11-25 |
2012-05-30 |
Almirall, S.A. |
New pyrazole derivatives having CRTh2 antagonistic behaviour
|
EP2463289A1
(en)
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
|
WO2012078804A1
(en)
|
2010-12-07 |
2012-06-14 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
EP2489663A1
(en)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Compounds as syk kinase inhibitors
|
JP2014507458A
(ja)
|
2011-03-11 |
2014-03-27 |
グラクソ グループ リミテッド |
Sykインヒビターとしてのピリド[3,4−B]ピラジン誘導体
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
US8834411B2
(en)
|
2011-04-06 |
2014-09-16 |
Mystic Pharmaceuticals, Inc. |
Medical devices for dispensing powders
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
EP2518070A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as PI3K inhibitors
|
EP2518071A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridine derivatives as PI3K inhibitors
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
EP2526945A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
New CRTH2 Antagonists
|
EP2527344A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
|
MX2013014399A
(es)
|
2011-06-08 |
2014-03-21 |
Glaxo Group Ltd |
Combinacion que comprende umeclidinio y un corticosteroide.
|
RU2013153202A
(ru)
|
2011-06-08 |
2015-07-20 |
Глаксо Груп Лимитед |
Композиции для ингалятора сухого порошка, содержащие умеклидиний
|
EP2548876A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists
|
EP2548863A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists.
|
EP2554544A1
(en)
|
2011-08-01 |
2013-02-06 |
Almirall, S.A. |
Pyridin-2(1h)-one derivatives as jak inhibitors
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
EP2578570A1
(en)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
|
EP2592077A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
EP2592078A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
US9603906B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Inhalable liquid formulations of DNase I
|
GB2499597A
(en)
*
|
2012-02-21 |
2013-08-28 |
Innovata Biomed Ltd |
Dry powder inhaler with stepped rotation of metering member
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
EP2647627A1
(en)
|
2012-04-02 |
2013-10-09 |
Almirall, S.A. |
Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
|
DE102012104850A1
(de)
|
2012-04-05 |
2013-10-10 |
Alfred Von Schuckmann |
Vorrichtung zur portionierten Ausgabe von Medikamenten
|
EP2836204B1
(en)
|
2012-04-13 |
2020-07-08 |
GlaxoSmithKline Intellectual Property Development Limited |
Aggregate particles
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
PE20142400A1
(es)
|
2012-04-27 |
2015-02-04 |
Glaxo Group Ltd |
Compuestos novedosos
|
EP2662105B1
(de)
|
2012-05-09 |
2017-01-18 |
Boehringer Ingelheim International GmbH |
Zerstäuber
|
FR2990872B1
(fr)
|
2012-05-24 |
2015-05-15 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
EP2666465A1
(en)
|
2012-05-25 |
2013-11-27 |
Almirall, S.A. |
Novel dosage and formulation
|
GB2502350A
(en)
|
2012-05-25 |
2013-11-27 |
Vectura Delivery Devices Ltd |
Inhaler having means to control the force applied to an actuating lever
|
EA201492044A1
(ru)
*
|
2012-05-25 |
2015-05-29 |
Арвен Айлак Санайи Ве Тиджарет А.С. |
Ингалятор, содержащий внутренний корпус, имеющий канал для воздуха
|
WO2013176639A1
(en)
*
|
2012-05-25 |
2013-11-28 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Inhaler device with an improved blister advancement mechanism
|
EP2668941A1
(en)
|
2012-05-31 |
2013-12-04 |
Almirall, S.A. |
Novel dosage form and formulation of abediterol
|
SG11201408411VA
(en)
*
|
2012-07-05 |
2015-01-29 |
Glaxo Group Ltd |
Inhaler device
|
WO2014060431A1
(en)
|
2012-10-16 |
2014-04-24 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
EP2738172A1
(en)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
SG11201503697TA
(en)
|
2012-11-28 |
2015-06-29 |
Intercept Pharmaceuticals Inc |
Treatment of pulmonary disease
|
JP5350530B1
(ja)
*
|
2012-12-07 |
2013-11-27 |
ニップファーマ株式会社 |
薬剤吸入デバイス
|
MA38260B1
(fr)
|
2012-12-18 |
2018-04-30 |
Almirall Sa |
Nouveaux dérivés de cyclohexyl et quinuclidinyl carbamate ayant une activité d'agoniste adrénergique beta2 et une activité d'antagoniste muscarinique m3
|
UY35332A
(es)
|
2013-02-15 |
2014-11-28 |
Almirall Sa |
Derivados de pirrolotriazina como inhibidores de pi3k
|
US9637456B2
(en)
|
2013-03-14 |
2017-05-02 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
|
JP6280573B2
(ja)
|
2013-03-14 |
2018-02-14 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited |
ブロモドメイン阻害薬としてのフロピリジン
|
GB201305668D0
(en)
|
2013-03-28 |
2013-05-15 |
Glaxosmithkline Ip Dev Ltd |
Avs6 Integrin Antagonists
|
JP6105373B2
(ja)
*
|
2013-04-25 |
2017-03-29 |
株式会社吉野工業所 |
吸引器具
|
JP5985434B2
(ja)
*
|
2013-04-25 |
2016-09-06 |
株式会社吉野工業所 |
吸引器具
|
RU2544801C2
(ru)
*
|
2013-06-11 |
2015-03-20 |
Открытое Акционерное Общество "Фармацевтическая Фабрика Санкт-Петербурга" |
Порошковый ингалятор
|
EP2848615A1
(en)
|
2013-07-03 |
2015-03-18 |
Almirall, S.A. |
New pyrazole derivatives as CRAC channel modulators
|
USD737425S1
(en)
|
2013-07-09 |
2015-08-25 |
Celon Pharma S.A. |
Inhaler
|
USD746378S1
(en)
|
2013-07-30 |
2015-12-29 |
Celon Pharma S.A. |
Label for an inhaler
|
USD759163S1
(en)
|
2013-07-30 |
2016-06-14 |
Celon Pharma S.A. |
Label for an inhaler
|
CN103624401B
(zh)
*
|
2013-08-20 |
2016-03-02 |
南京理工大学 |
立式定量控制的自动爆炸复合炸药铺放装置
|
WO2015091285A1
(en)
|
2013-12-19 |
2015-06-25 |
Almirall S.A. |
Dosage formulation comprising salmeterol and fluticasone propionate
|
WO2015097662A1
(en)
|
2013-12-23 |
2015-07-02 |
Glenmark Pharmaceuticals Ltd |
A dry powder inhaler
|
EA201692111A1
(ru)
|
2014-05-12 |
2017-08-31 |
Глаксосмитклайн Интеллекчуал Проперти (№ 2) Лимитед |
Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
|
EP4252742A3
(en)
|
2014-05-28 |
2023-12-27 |
GlaxoSmithKline Intellectual Property Development Ltd |
Fluticasone furoate in the treatment of copd
|
EP2957552B1
(en)
|
2014-06-16 |
2020-01-22 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Vilanterol formulations
|
MA39288A
(fr)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret As |
Formulations pharmaceutiques comprenant du vilanterol
|
TR201407010A2
(tr)
|
2014-06-16 |
2015-12-21 |
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi |
Vilanterol formülasyonları.
|
EP2957553A1
(en)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical formulations of vilanterol
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
US9550032B2
(en)
*
|
2014-10-12 |
2017-01-24 |
Kendra Baldwin |
Wearable wrist inhaler
|
EP3212212B1
(en)
|
2014-10-31 |
2020-09-23 |
Monash University |
Powder formulation
|
MX2017009112A
(es)
|
2015-01-14 |
2018-06-15 |
Respira Therapeutics Inc |
Metodos y dispositivos de dispersion de polvo.
|
GB201503720D0
(en)
|
2015-03-05 |
2015-04-22 |
Glaxosmithkline Ip No 2 Ltd |
Chemical compound
|
TW201643179A
(zh)
|
2015-03-11 |
2016-12-16 |
葛蘭素史克智慧財產發展有限公司 |
Tslp結合蛋白
|
USD767114S1
(en)
|
2015-03-18 |
2016-09-20 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
USD769439S1
(en)
|
2015-03-18 |
2016-10-18 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
GB201504689D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
CN106139335B
(zh)
*
|
2015-04-09 |
2022-12-16 |
正大天晴药业集团股份有限公司 |
一种药粉释放装置
|
WO2016161830A1
(zh)
*
|
2015-04-09 |
2016-10-13 |
正大天晴药业集团股份有限公司 |
药物释放带
|
TWI597079B
(zh)
*
|
2015-04-10 |
2017-09-01 |
微劑量醫療公司 |
泡殼帶進給機構
|
US10214509B2
(en)
|
2015-04-21 |
2019-02-26 |
Almirall, S.A. |
Amino-substituted heterocyclic derivatives as sodium channel inhibitors
|
AU364719S
(en)
|
2015-05-20 |
2015-10-14 |
Korea United Pharm Inc |
Medicine inhaler
|
CA2988374A1
(en)
|
2015-06-15 |
2016-12-22 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 regulators
|
MX2017016405A
(es)
|
2015-06-15 |
2018-05-22 |
Glaxosmithkline Ip Dev Ltd |
Reguladores de nrf2.
|
CA2988373A1
(en)
|
2015-06-15 |
2016-12-22 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 regulators
|
WO2016202800A1
(en)
|
2015-06-16 |
2016-12-22 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
CN107614037B
(zh)
*
|
2015-07-29 |
2021-09-03 |
正大天晴药业集团股份有限公司 |
药物释放带
|
UY36851A
(es)
|
2015-08-16 |
2017-03-31 |
Glaxosmithkline Ip Dev Ltd |
Compuestos para uso en aplicaciones antibacterianas
|
EP3353162A1
(en)
|
2015-09-22 |
2018-08-01 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pyridinone dicarboxamide for use as bromodomain inhibitors
|
WO2017060854A1
(en)
|
2015-10-06 |
2017-04-13 |
Glaxosmithkline Intellectual Property Development Limited |
Biaryl pyrazoles as nrf2 regulators
|
EP3371167A1
(en)
|
2015-10-06 |
2018-09-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Arylcyclohexyl pyrazoles as nrf2 regulators
|
JP2018535984A
(ja)
|
2015-11-18 |
2018-12-06 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited |
リバビリンの医薬組成物
|
GB201604680D0
(en)
|
2016-03-21 |
2016-05-04 |
Glaxosmithkline Ip Dev Ltd |
Chemical Compounds
|
CA3018275A1
(en)
|
2016-04-07 |
2017-10-12 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Benzo[b]furans as bromodomain inhibitors
|
AU2017245641A1
(en)
|
2016-04-07 |
2018-09-13 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Pyridyl derivatives as bromodomain inhibitors
|
WO2017176291A1
(en)
*
|
2016-04-08 |
2017-10-12 |
Kendra Baldwin T |
Wearable wrist inhaler
|
JP6885968B2
(ja)
|
2016-05-24 |
2021-06-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited |
ブロモドメイン阻害薬としてのピリジンジカルボキサミド誘導体
|
GB201614934D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
GB201614939D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Ip Dev Ltd |
Crystalline hydrate
|
GB201614940D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
CA3036933A1
(en)
|
2016-09-20 |
2018-03-29 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Trpv4 antagonists
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產(第二)有限公司 |
Trpv4拮抗劑
|
WO2018055527A1
(en)
|
2016-09-20 |
2018-03-29 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Trpv4 antagonists
|
CN109045427B
(zh)
*
|
2016-10-03 |
2021-06-25 |
捷普科技(上海)有限公司 |
药剂分配器
|
US20190307975A1
(en)
|
2016-11-21 |
2019-10-10 |
Lupin Inc. |
Medicament dispenser
|
CN108779108A
(zh)
|
2016-12-06 |
2018-11-09 |
葛兰素史密斯克莱知识产权发展有限公司 |
3-(2,3-二氢-1h-茚-5-基)丙酸衍生物和它们作为nrf2调节剂的用途
|
JP2020500918A
(ja)
|
2016-12-12 |
2020-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしてのn−アリールピラゾール
|
WO2018109641A1
(en)
|
2016-12-12 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
3-carboxylic acid pyrroles as nrf2 regulators
|
US11117905B2
(en)
|
2016-12-14 |
2021-09-14 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl heterocycles as NRF2 activators
|
US20220002272A1
(en)
|
2016-12-14 |
2022-01-06 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl lactams as nrf2 activators
|
US11078216B2
(en)
|
2016-12-14 |
2021-08-03 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl amides as NRF2 activators
|
JP7110197B2
(ja)
|
2016-12-15 |
2022-08-01 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド |
Nrf2アクチベーター
|
JP2020502152A
(ja)
|
2016-12-15 |
2020-01-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2アクチベーターとしてのエーテル結合トリアゾール
|
US10702495B2
(en)
|
2017-02-20 |
2020-07-07 |
Nexien Biopharma, Inc. |
Method and compositions for treating dystrophies and myotonia
|
GB201703282D0
(en)
|
2017-03-01 |
2017-04-12 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
CN108622469B
(zh)
*
|
2017-03-24 |
2023-08-15 |
李和伟 |
一种独立包装的履带式给药器
|
US11167022B2
(en)
|
2017-03-31 |
2021-11-09 |
Glaxosmithkline Intellectual Property Development Limited |
Immunogenic composition, use and method of treatment
|
US11014941B2
(en)
|
2017-04-24 |
2021-05-25 |
Cocrystal Pharma, Inc. |
Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
|
ES2932836T3
(es)
|
2017-07-25 |
2023-01-26 |
Adherium Nz Ltd |
Procedimiento y dispositivo de control de la adherencia
|
TW201919682A
(zh)
|
2017-08-08 |
2019-06-01 |
西班牙商阿爾米雷爾有限公司 |
活化Nrf2路徑的新穎化合物
|
GB201716369D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
GB201716392D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
US20210177861A1
(en)
|
2017-12-11 |
2021-06-17 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
CA3088347A1
(en)
|
2018-01-17 |
2019-07-25 |
Glaxosmithkline Intellectual Property Development Limited |
Pi4kiii.beta. inhibitors
|
CN110237373B
(zh)
*
|
2018-03-08 |
2023-06-02 |
润生药业有限公司 |
一种生产用于联合用药的药物载体的装置及方法
|
US20210085897A1
(en)
|
2018-04-06 |
2021-03-25 |
Lupin Inc. |
Medicament dispenser
|
WO2019224667A1
(en)
|
2018-05-23 |
2019-11-28 |
Glaxosmithkline Intellectual Property Development Limited |
Indanes as nrf2 activators
|
MX2021000917A
(es)
|
2018-07-27 |
2021-06-23 |
Cocrystal Pharma Inc |
Derivados de pirrolo[2,3-b]piridina como inhibidores de la replicación del virus de la gripe.
|
GB201812671D0
(en)
|
2018-08-03 |
2018-09-19 |
Coalesce Product Dev Ltd |
An inhaler device
|
GB201814167D0
(en)
|
2018-08-31 |
2018-10-17 |
Glaxosmithkline Ip No 2 Ltd |
Compounds
|
CN113286793B
(zh)
|
2018-09-10 |
2024-04-05 |
共结晶制药公司 |
吡咯并吡嗪和吡啶并三嗪类流感病毒复制抑制剂
|
CA3112309C
(en)
|
2018-09-10 |
2024-06-04 |
Cipla Limited |
Single blister-strip based dispenser
|
MX2021004215A
(es)
|
2018-10-17 |
2021-07-15 |
Cocrystal Pharma Inc |
Combinaciones de inhibidores de la replicación del virus de la gripe.
|
EA202191327A1
(ru)
|
2018-11-13 |
2021-08-09 |
Кокристал Фарма, Инк. |
Лекарственные формы терапевтических препаратов от гриппа
|
EP3887355A1
(en)
|
2018-11-26 |
2021-10-06 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
BR112021021775A2
(pt)
|
2019-04-29 |
2022-01-04 |
Insmed Inc |
Composições de pó seco de pró-fármacos de treprostinil e métodos de uso destas
|
EP3750528A1
(en)
|
2019-06-11 |
2020-12-16 |
Nexien Biopharma, Inc. |
Compositions for treating dystrophies and myotonia
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
EP4114743A1
(en)
|
2020-03-06 |
2023-01-11 |
Vectura Delivery Devices Limited |
Process for manufacturing a blister strip for a dry powder inhaler
|
WO2021188620A1
(en)
|
2020-03-17 |
2021-09-23 |
Cocrystal Pharma Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
CA3176877A1
(en)
|
2020-03-25 |
2021-09-30 |
Lupin Inc. |
Multi-carrier medicament dispensers
|
KR20230008079A
(ko)
|
2020-04-10 |
2023-01-13 |
코크리스탈 파마, 아이엔씨. |
노로바이러스 및 코로나바이러스 복제 억제제
|
EP4138884A1
(en)
|
2020-04-20 |
2023-03-01 |
Sorrento Therapeutics, Inc. |
Pulmonary administration of ace2 polypeptides
|
EP4061457A1
(en)
|
2020-06-15 |
2022-09-28 |
Norton (Waterford) Limited |
Blister pack and inhaler comprising the same
|
PL244221B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
PL244222B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
WO2022175423A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition, use and methods
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
CA3227602A1
(en)
|
2021-08-03 |
2023-02-09 |
Irina C. Jacobson |
Inhibitors for coronaviruses
|
GB202111658D0
(en)
|
2021-08-13 |
2021-09-29 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
EP4331647A3
(en)
|
2021-08-13 |
2024-05-29 |
Norton (Waterford) Limited |
Dry powder medicament inhaler
|
WO2023052477A1
(en)
|
2021-09-29 |
2023-04-06 |
Norton (Waterford) Limited |
Dry powder medicament inhaler
|
AU2022354108A1
(en)
|
2021-09-29 |
2024-03-28 |
Norton (Waterford) Limited |
Dry powder medicament inhaler
|
GB202113921D0
(en)
|
2021-09-29 |
2021-11-10 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
CN114178071B
(zh)
*
|
2021-12-10 |
2022-09-09 |
杭州博乐工业设计股份有限公司 |
一种可更换储液设备的喷雾器
|
WO2023150747A1
(en)
|
2022-02-07 |
2023-08-10 |
Insmed Incorporated |
Dry powder compositions of bedaquiline and salts and methods of use thereof
|
GB2618145A
(en)
*
|
2022-04-29 |
2023-11-01 |
Merxin Ltd |
Manifold
|